#: locale=en

## Tour

### Description

### Title
tour.name = Relmada Therapeutics

## Skin

### Button
Button_9D077CFF_A968_9131_41A1_C42F7656C8BE.label = Reception
Button_D15CFE5E_CCD0_D950_41DA_C43F3781D52E.label = VIEW
Button_D15D8E61_CCD0_D970_41B5_DC4353DD8405.label = VIEW
Button_D15E7E64_CCD0_D970_41DF_E2BD0B0200F8.label = VIEW
Button_D15ECE68_CCD0_D970_41E7_723C488D5E9B.label = VIEW
Button_D1B72CFE_CCD0_7950_41E7_BFE3A6869F86.label = VIEW
Button_D1ECF1F0_CCD0_6B50_41E6_ED7EC0AF6B3B.label = VIEW
Button_D1FE3673_CCD0_6950_41D7_5D217763744B.label = VIEW
Button_D2F7BFB9_CCD0_D7D3_41D5_8F4DF69D662B.label = VIEW
Button_D5038DC2_CC30_DBB0_41E6_ED48EF1C62BE.label = Contact Us
Button_D8CAFC33_CC30_D8D0_41E5_726A702A0CD6.label = Exhibition area
Button_F4004A42_E42A_57AF_41E0_9DD5CF308F5C.label = GO TO BUY 
Button_F4066A44_E42A_57AA_41E9_EB0251C999AE.label = More info:

### Multiline Text
HTMLText_9D079D00_A968_90CF_41C7_BC63F0D98479.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.29px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:22.29px;font-family:Arial, Helvetica, sans-serif;"/></p></div>
HTMLText_D15C2E5C_CCD0_D950_41D7_1AA6D2FDB54E.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">Characterization of Esmethadone and Other NMDAR Channel Blockers on Human Heterodimeric N-methyl-D-aspartate Receptors</SPAN></SPAN></DIV></div>
HTMLText_D15D5E5F_CCD0_D950_41E4_EFBA9F8D38FB.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">REL-1017 (esmethadone; d-methadone) Did Not Produce Initial or Cumulative Neurotoxic Effects or Other Evidence of Damage to Cortical Neurons in Sprague Dawley Rats</SPAN></SPAN></DIV></div>
HTMLText_D15DBE63_CCD0_D970_41E2_961B96D47EA9.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">REL-1017 (esmethadone; d-methadone) as Adjunctive Treatment in Patients with Major Depressive Disorder: A Phase 2a Double-Blind Randomized Trial </SPAN></SPAN></DIV></div>
HTMLText_D15EFE66_CCD0_D970_41C5_F3E7AB8E42CA.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">A Phase 2a Double-Blind Randomized Trial of REL-1017 in Patients with Major Depressive Disorder: Analysis of Subscales from the Symptoms of Depression Questionnaire</SPAN></SPAN></DIV></div>
HTMLText_D1B6CCFC_CCD0_7950_41E2_645889FBB9E0.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">REL-1017 (esmethadone; d-Methadone): Assessment of Reinforcement-type Behavior, Physical Dependence, and Withdrawal in Sprague </SPAN></SPAN></DIV><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">Dawley Rats</SPAN></SPAN></DIV></div>
HTMLText_D1EC41E9_CCD0_6B70_41D2_8FFF3874C645.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">No Meaningful Opioid Abuse Liability of REL-1017 (esmethadone; d-methadone), a Rapid-Acting Antidepressant in Clinical Development: A Human Abuse Potential Study</SPAN></SPAN></DIV></div>
HTMLText_D1FDF66C_CCD0_6970_41D6_3148A0C6DA60.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">Effect of REL-1017 (esmethadone; d-methadone) on Cholesterol, Triglycerides, PCSK9, and hs-CRP in Patients with Major Depressive Disorder</SPAN></SPAN></DIV></div>
HTMLText_D252DD64_CCD1_DB70_41C8_BD519593DFFB.html = <div style="text-align:left; color:#000; "><p STYLE="margin:0; line-height:22.24px;"><BR STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-size:19.06px;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:center;font-size:22.23529411764706px;"><SPAN STYLE="display:inline-block; letter-spacing:0px; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#ffffff;font-size:22.24px;font-family:'SVN-Gotham Book';">Case Report: REL-1017 Reduces Abnormal Clinician Administered Dissociative States Scale Scores in Patients with Major Depressive Disorder </SPAN></SPAN></DIV></div>
HTMLText_F4029A42_E42A_57AF_41C6_F8FA3488D3DB.html = <div style="text-align:left; color:#000; "><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="color:#f15507;font-size:1.23vw;font-family:'Arial Narrow';">Firing of roof tiles</SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.7423287095418247vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:1.74vw;font-family:'Arial Narrow';"><B>H-Cassettes</B></SPAN></SPAN></DIV><p STYLE="margin:0; line-height:1.23vw;"><BR STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-size:5.9vw;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';"><B>Application:</B></SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:0.92vw;font-family:'Arial Narrow';">  •  </SPAN><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';">Firing of high-quality roof tiles</SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:0.92vw;font-family:'Arial Narrow';">  •  </SPAN><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';">Especially for glazed and engobed roof tiles</SPAN></SPAN></DIV><p STYLE="margin:0; line-height:1.23vw;"><BR STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-size:5.9vw;font-family:Arial, Helvetica, sans-serif;"/></p><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';"><B>Advantages:</B></SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:0.92vw;font-family:'Arial Narrow';">  •  </SPAN><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';">Low energy consumption due to the BURCORIT® KF1 material</SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:0.92vw;font-family:'Arial Narrow';">  •  </SPAN><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';">No sagging of roof tiles</SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:0.92vw;font-family:'Arial Narrow';">  •  </SPAN><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';">No adhesion between roof tiles</SPAN></SPAN></DIV><DIV STYLE="text-align:left;font-size:1.2295081967213104vw;"><SPAN STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-family:Arial, Helvetica, sans-serif;"><SPAN STYLE="font-size:0.92vw;font-family:'Arial Narrow';">  •  </SPAN><SPAN STYLE="font-size:1.23vw;font-family:'Arial Narrow';">Light weight  cassette for low energy consumption</SPAN></SPAN></DIV><p STYLE="margin:0; line-height:1.23vw;"><BR STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-size:5.9vw;font-family:Arial, Helvetica, sans-serif;"/></p><p STYLE="margin:0; line-height:1.23vw;"><BR STYLE="display:inline-block; letter-spacing:0vw; white-space:pre-wrap;color:#000000;font-size:5.9vw;font-family:Arial, Helvetica, sans-serif;"/></p></div>

### Label
Label_0FA90BCA_2E9F_E075_41A2_F6E5A947EFDB.text = FLOOR PLAN
Label_30ABBA96_2E98_E01D_41C3_E8B9CBD0CD5D.text = CHAT BOX
Label_70E11281_426A_C726_41B8_D61492124DBB.text = Imprint and Disclaimer
Label_74039092_650E_1C64_41A3_E22A232B5732.text = DISCLAIMER
Label_9F4C8A3C_8133_98B7_41D8_AA726B9CF5BE.text = SCORE: {{quiz.score2.items.found}}/{{quiz.score2.item.count}}
Label_CBF9DE93_5DC8_D82B_41D5_9BD62CA9A2D8.text = CONTACT US
Label_CE02E01F_D7D4_9E92_41B5_710A55A37378.text = Powered by AddVideos.com
Label_D1A2B253_A9AF_B170_41DC_5E4FDEEFF704.text = Green Light color
Label_D1C4E6DF_5C48_C9DB_419C_8FC196459B2C.text = CONTACT US
Label_D2548DE5_A9AF_B350_41D9_4E39362F4A78.text = Blue Light color
Label_D254E83C_A9AF_B130_41CB_134DC513EF99.text = Red Light color
Label_D2F39D18_A9E8_70F0_41E1_239C765E2ED4.text = Dark color
Label_D4A7E5D2_A8E8_9370_41C0_0675F394F353.text = Theme:
Label_D738AE9A_CC30_79D0_41A2_3C31F2C1EE14.text = POSTERS
Label_F407A868_E42A_D47A_41DF_71B7E7D792F9.text = Anode baking furnaces - Open Type
Label_F4087A4C_E42A_57BA_41E2_E011633F2A16.text = More info: 
Label_F638471F_61DA_107A_41C7_12623FF2BBA4.text = Explore KIOXIA's Technology and Solutions

### Tooltip
Container_D1C446DF_5C48_C9DB_41C5_C9E8217722A9.toolTip = Connect'On 
IconButton_8744B8CF_C556_3963_41E1_9EBCAF9084E6.toolTip = Organize a call!
IconButton_94C01793_A999_FFF0_41DC_922FAECB97ED.toolTip = Chat with us!
IconButton_9D078D00_A968_90CF_41C2_96F4214C965E.toolTip = Lock/Un lock camera 
IconButton_9D07BD00_A968_90CF_41DE_69190C4C41C5.toolTip = On/off sound 
IconButton_9D07CD00_A968_90CF_41E3_44C1C3EB5423.toolTip = Fullscreen
WebFrame_CBFE2E93_5DC8_D82B_41CB_3C6BA7040B89.toolTip = Connect'ON

## Media

### Title
panorama_F153DBB7_E00A_46BE_41B7_F19BF229E824.label = 01
panorama_F16F6CE1_E00E_C2D2_41C0_208A8758F260.label = 00
video_C715F190_D7ED_9E6E_41D5_BDCF8D602376.label = Central monitor screensaver
video_C7C3F9F6_D7D4_A193_41E3_D854286824F5.label = Left monitor screensaver

## Action

### PDF
PopupPDFBehaviour_C26315C6_D7FB_E1F2_41D2_004E41C43B29.url = files/Brochure_en.pdf
PopupPDFBehaviour_D024E6A0_CCF0_29F0_41E4_C71E1AC79CF6.url = files/06 NEI_Olneys_en.pdf
PopupPDFBehaviour_D02A4707_CCF0_28B0_41DC_76DFB30FB24F.url = files/01 NEI CADSS_en.pdf
PopupPDFBehaviour_D04D67BF_CCF0_77D0_41CC_1A815C10131A.url = files/07 NEI_Phase2_en.pdf
PopupPDFBehaviour_D05C2FB8_CCF0_57D0_41E3_F6783A78EE73.url = files/06 NEI_Olneys (1)_en.pdf
PopupPDFBehaviour_D06A9B9C_CCF0_5FD0_41B0_4CF3AC696793.url = files/08 NEI_SDQ_en.pdf
PopupPDFBehaviour_D07D6160_CCF0_6B70_41D5_92D3D05B8330.url = files/07 NEI_Phase2_en.pdf
PopupPDFBehaviour_D11D5965_CCF0_FB70_41E1_8B3CE9F42C32.url = files/03 NEI_Human Abuse_en.pdf
PopupPDFBehaviour_D13041E1_CCF0_EB70_41DF_FD52D223C939.url = files/04 NEI_Metabolic_en.pdf
PopupPDFBehaviour_D131D21B_CCF0_28D0_41E6_11DCA175F01D.url = files/01 NEI CADSS_en.pdf
PopupPDFBehaviour_D150EAE4_CCF0_D970_41C5_7021DDE2BA47.url = files/04 NEI_Metabolic_en.pdf
PopupPDFBehaviour_D17E0520_CCF0_28F0_41E0_2FE6A3FF17F5.url = files/05 NEI_MOA_en.pdf
PopupPDFBehaviour_D19BC547_CCF0_28B0_41BB_A8FD85A03BD3.url = files/08 NEI_SDQ_en.pdf
PopupPDFBehaviour_D1DD7BBA_CCF0_3FD0_41B5_414DDD883645.url = files/02 NEI_Experimental Abuse_en.pdf
PopupPDFBehaviour_D1E23FF5_CCF0_D750_41CD_BDD18FB07CF4.url = files/03 NEI_Human Abuse_en.pdf
PopupPDFBehaviour_D1F1C561_CCF0_2B70_41D9_0B07309C0121.url = files/02 NEI_Experimental Abuse_en.pdf
PopupPDFBehaviour_D2996E19_CCF0_38D0_41CC_5B9ABCED8371.url = files/05 NEI_MOA_en.pdf
PopupPDFBehaviour_D4495363_CC70_2F70_41E4_79588DFFEB1D.url = files/Brochure_en.pdf
PopupPDFBehaviour_D4628FE0_CC70_3770_41B6_CA7E2093432E.url = files/Brochure_en.pdf
PopupPDFBehaviour_D59E7ED5_CC50_7950_41E0_95B8D20843CB.url = files/Podium 1_en.pdf
PopupPDFBehaviour_D5D0C428_CC50_E8F1_41E1_F7F91B87ADF1.url = files/Podium 1_en.pdf
PopupPDFBehaviour_D65E5A29_CC50_38F0_41D6_DFFD3703ACEF.url = files/Podium 2_en.pdf
PopupPDFBehaviour_D67D1656_CC50_2950_41D6_6784D0B783CF.url = files/Podium 2_en.pdf
PopupPDFBehaviour_D81CB65E_D7D4_6293_41EA_0C1A6A330E08.url = files/Left monitor slideshow_en.pdf
PopupPDFBehaviour_D820B36D_D7EC_A2B6_41AB_4CA7780F38B1.url = files/Left monitor slideshow_en.pdf
PopupPDFBehaviour_D85642BD_D7EF_A391_41DC_9555AB816BF6.url = files/Central monitor slideshow_en.pdf
PopupPDFBehaviour_D8586493_D7EC_6791_41E4_3ABA09623FB7.url = files/Central monitor slideshow_en.pdf

### URL
LinkBehaviour_20518D6D_3E2A_BDFE_41AA_E4D71007001C.source = http://www.softathome.com/
LinkBehaviour_2CB506C9_3E3A_4B2B_41C7_5B88A1AA9AF3.source = https://www.facebook.com/Refratechnik/
LinkBehaviour_2CB566C9_3E3A_4B2B_41C0_3DDA8DECDB5E.source = https://twitter.com/relmada?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkBehaviour_72F2C6AF_5E36_3037_41CE_DB02E46154F9.source = https://www.relmada.com/
LinkBehaviour_7320C6D9_5E6A_101B_41D4_6F0C814818A5.source = https://www.instagram.com/refratechnik/
LinkBehaviour_C2ED54AA_D7F7_E7B2_41D7_954FA16E5EBF.source = https://events.boothhoster.com/blsgroup/index.htm
LinkBehaviour_C7C987EC_D7DD_A1B6_41D2_29F52A1B504A.source = https://www.relmada.com/about/contact
LinkBehaviour_CF276A6D_D7D4_A2B1_4190_FA18886F2AB3.source = https://addvideos.com/
LinkBehaviour_D7433F8C_CF3B_8855_41BB_B8F70DFC9A59.source = https://events.boothhoster.com/blsgroup/index.htm
LinkBehaviour_D8B23B43_D7DB_E2F2_41D8_258653C23401.source = https://www.relmada.com/about/contact
LinkBehaviour_DA73B3BB_CF5F_9FB2_41DD_95653F173492.source = https://www.linkedin.com/company/relmada-therapeutics-inc/
LinkBehaviour_DAADDFA4_CF44_8855_41D6_767F8E2AC062.source = https://www.linkedin.com/company/relmada-therapeutics-inc/
LinkBehaviour_DABB0DA8_CF5C_885D_4182_4204019A40B0.source = https://twitter.com/relmada?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkBehaviour_DC0F2EFD_CF5C_89B7_41E1_64F8F0522B0D.source = https://www.relmada.com/about/contact
LinkBehaviour_DC7CBC15_CF45_8877_417E_EBCF0B75CF67.source = https://www.linkedin.com/company/relmada-therapeutics-inc/
LinkBehaviour_DCB1827A_CF47_98BD_41C2_9971527CFAB0.source = https://twitter.com/relmada?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkBehaviour_DDD6BEEE_CF47_89D5_41D8_9792CED10680.source = https://twitter.com/relmada?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
LinkBehaviour_DE09EE6E_FFD6_1FB2_41EB_1C237D9AA542.source = https://www.linkedin.com/company/relmada-therapeutics-inc/
LinkBehaviour_DEB41A75_FFD6_6796_41E0_74F73163431A.source = https://www.youtube.com/Refratechnikgroup